LANDMARK SCHIZOPHRENIA DATA THAT BRINGS HOPE IN BREAKING THE CYCLE OF HOSPITALIZATION AND INCARCERATION RECEIVES FDA APPROVAL FOR INCLUSION IN INVEGA SUSTENNA ® (paliperidone palmitate) LABEL

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news